CancerIQ Expands Diagnostic Network with Addition of geneType™ PRS Test from Rhythm Biosciences

Now available for clinical ordering across CancerIQ's network of 60+ health systems CHICAGO, June 2, 2026 /PRNewswire/ -- CancerIQ today announced that the geneType™ Cancer Risk Assessment from Rhythm Biosciences is now available on the CancerIQ platform, expanding the tools providers can...